MedicationUse2-v3.0(2024EN) - Bewerkingsoverzicht

Update bot op 27 mei 2025 om 15:55

2025-05-27T15:55:22Z

← Oudere versie		Versie van 27 mei 2025 17:55
Regel 8:		Regel 8:
	Release<!--hdPublication-->: '''2024''' <br>		Release<!--hdPublication-->: '''2024''' <br>
	Release status<!--hdPublicationStatus-->: Published<br>		Release status<!--hdPublicationStatus-->: Published<br>
	Release date<!--hdPublicationDate-->: 23-04-~~2025~~		Release date<!--hdPublicationDate-->: 24-04-2024
	<!-- Aanroep Errata transclude page -->		<!-- Aanroep Errata transclude page -->
	{{ErrataEN<!--hdErrata-->\|2024\|{{PAGENAME}}}}		{{ErrataEN<!--hdErrata-->\|2024\|{{PAGENAME}}}}
Regel 50:		Regel 50:
	\|style="width:250px; "\|DCM::Name\|\|nl.zorg.MedicatieGebruik2		\|style="width:250px; "\|DCM::Name\|\|nl.zorg.MedicatieGebruik2
	\|-		\|-
	\|style="width:250px; "\|DCM::PublicationDate\|\|23-04-~~2025~~		\|style="width:250px; "\|DCM::PublicationDate\|\|24-04-2024
	\|-		\|-
	\|style="width:250px; "\|DCM::PublicationStatus\|\|Published		\|style="width:250px; "\|DCM::PublicationStatus\|\|Published
Regel 102:		Regel 102:
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_2#ZIB-1261 \| ZIB-1261 ]]		\|style="width:75px; "\|[[ZIBIssues500_2#ZIB-1261 \| ZIB-1261 ]]
	\|~~Geen informatie~~		\|Medicatieafspraak waardelijst MedicatieafspraakStopTypeCodelijst bevat vervallen SNOMED CT codes
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_2#ZIB-1454 \| ZIB-1454 ]]		\|style="width:75px; "\|[[ZIBIssues500_2#ZIB-1454 \| ZIB-1454 ]]
	\|~~Geen informatie~~		\|Onduidelijkheid codes bij StopType codelijsten
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_3#ZIB-1575 \| ZIB-1575 ]]		\|style="width:75px; "\|[[ZIBIssues500_3#ZIB-1575 \| ZIB-1575 ]]
	\|~~Geen informatie~~		\|Deprecated termen en waardelijsten uit de prepublicatie halen
	\|}		\|}

Regel 115:		Regel 115:
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_3#ZIB-1685 \| ZIB-1685 ]]		\|style="width:75px; "\|[[ZIBIssues500_3#ZIB-1685 \| ZIB-1685 ]]
	\|~~Geen informatie~~		\|Medicatiebouwstenen MA, TA, MGB - engelse vertaling van 'tot en met'
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_3#ZIB-1725 \| ZIB-1725 ]]		\|style="width:75px; "\|[[ZIBIssues500_3#ZIB-1725 \| ZIB-1725 ]]
	\|~~Geen informatie~~		\|Verzameling errata bouwsteen Medicatiegebruik
	\|}		\|}

Regel 125:		Regel 125:
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_3#ZIB-1965 \| ZIB-1965 ]]		\|style="width:75px; "\|[[ZIBIssues500_3#ZIB-1965 \| ZIB-1965 ]]
	\|~~Geen informatie~~		\|Voorbeeld medicatiegebruik gebruiksduur: maand niet toegestaan
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_3#ZIB-1974 \| ZIB-1974 ]]		\|style="width:75px; "\|[[ZIBIssues500_3#ZIB-1974 \| ZIB-1974 ]]
	\|~~Geen informatie~~		\|Suggested typo and textual improvements
	\|}		\|}

Regel 135:		Regel 135:
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_4#ZIB-2091 \| ZIB-2091 ]]		\|style="width:75px; "\|[[ZIBIssues500_4#ZIB-2091 \| ZIB-2091 ]]
	\|~~Geen informatie~~		\|MGB/RedenWijzigenOfStoppenGebruik: toevoegen 'loopt in andere medicamenteuze behandeling'
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_4#ZIB-2092 \| ZIB-2092 ]]		\|style="width:75px; "\|[[ZIBIssues500_4#ZIB-2092 \| ZIB-2092 ]]
	\|~~Geen informatie~~		\|Kardinaliteit gebruiksperiode
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_4#ZIB-2132 \| ZIB-2132 ]]		\|style="width:75px; "\|[[ZIBIssues500_4#ZIB-2132 \| ZIB-2132 ]]
	\|~~Geen informatie~~		\|2023-1 Verwijzingen naar FarmaceutischProduct gebruiken verkeerde NL-CM id
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_4#ZIB-2133 \| ZIB-2133 ]]		\|style="width:75px; "\|[[ZIBIssues500_4#ZIB-2133 \| ZIB-2133 ]]
	\|~~Geen informatie~~		\|2023-1 Verwijzingen naar Gebruiksinstructie gebruiken verkeerde NL-CM id
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_4#ZIB-2152 \| ZIB-2152 ]]		\|style="width:75px; "\|[[ZIBIssues500_4#ZIB-2152 \| ZIB-2152 ]]
	\|~~Geen informatie~~		\|MedicatieGebruik: gebruiksindicator SNOMED koppeling
	\|-		\|-
	\|style="width:75px; "\|[[ZIBIssues500_4#ZIB-2153 \| ZIB-2153 ]]		\|style="width:75px; "\|[[ZIBIssues500_4#ZIB-2153 \| ZIB-2153 ]]
	\|~~Geen informatie~~		\|MedicatieGebruik: RedenGebruik SNOMED koppeling mist
	\|}		\|}
	</div>		</div>
Regel 170:		Regel 170:
	rect 480 43 592 107 [[InstructionsForUse-v3.1(2024EN)]]		rect 480 43 592 107 [[InstructionsForUse-v3.1(2024EN)]]
	rect 776 188 887 252 [[#1604]]		rect 776 188 887 252 [[#1604]]
	rect 330 43 442 107 [[PharmaceuticalProduct-v2.~~2.1~~(2024EN)]]		rect 330 43 442 107 [[PharmaceuticalProduct-v2.3(2024EN)]]
	rect 775 45 887 115 [[#1609]]		rect 775 45 887 115 [[#1609]]
	rect 171 181 313 251 [[#1602]]		rect 171 181 313 251 [[#1602]]
Regel 221:		Regel 221:
	{\|		{\|
	\|-		\|-
	\|[[Bestand: block.png \| link=PharmaceuticalProduct-v2.~~2.1~~(2024EN)]]\|\|[[PharmaceuticalProduct-v2.~~2.1~~(2024EN) \|PharmaceuticalProduct]]		\|[[Bestand: block.png \| link=PharmaceuticalProduct-v2.3(2024EN)]]\|\|[[PharmaceuticalProduct-v2.3(2024EN) \|PharmaceuticalProduct]]
	\|}		\|}
	\|-style="vertical-align:top; background-color: transparent; "		\|-style="vertical-align:top; background-color: transparent; "
Regel 643:		Regel 643:
	*[[HealthProfessional-v4.0.1(2024EN)\|HealthProfessional-v4.0.1]]		*[[HealthProfessional-v4.0.1(2024EN)\|HealthProfessional-v4.0.1]]
	*[[InstructionsForUse-v3.1(2024EN)\|InstructionsForUse-v3.1]]		*[[InstructionsForUse-v3.1(2024EN)\|InstructionsForUse-v3.1]]
	*[[PharmaceuticalProduct-v2.~~2.1~~(2024EN)\|PharmaceuticalProduct-v2.~~2.1~~]]		*[[PharmaceuticalProduct-v2.3(2024EN)\|PharmaceuticalProduct-v2.3]]
	*[[TimeInterval-v1.3(2024EN)\|TimeInterval-v1.3]]		*[[TimeInterval-v1.3(2024EN)\|TimeInterval-v1.3]]
	====This information model is used in<!--ftReferredBy-->====		====This information model is used in<!--ftReferredBy-->====
Regel 660:		Regel 660:
	SNOMED CT and LOINC codes are based on:		SNOMED CT and LOINC codes are based on:
	<ul>		<ul>
	<li>SNOMED Clinical Terms versie: ~~20250331~~ [R] (~~maart~~ 2025-editie)</li>		<li>SNOMED Clinical Terms versie: 20250430 [R] (april 2025-editie)</li>
	<li>LOINC version 2.77</li>		<li>LOINC version 2.77</li>
	</ul>		</ul>
	Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png\|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>		Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png\|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
	This page is generated on 18/04/2025 16:32:30 with ZibExtraction v. 9.4.~~9209~~.~~40417~~<!--ftDate--> <BR>		This page is generated on 27/05/2025 13:59:25 with ZibExtraction v. 9.5.9242.40707<!--ftDate--> <BR>
	-----		-----
	<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png\| link= HCIM_Release<!--wikiReleasePage-->_2024(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2024(EN) \|Back to HCIM list<!--hdBackToMainPage--> ]]</div>		<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png\| link= HCIM_Release<!--wikiReleasePage-->_2024(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2024(EN) \|Back to HCIM list<!--hdBackToMainPage--> ]]</div>

Update bot op 18 apr 2025 om 16:24

2025-04-18T16:24:58Z

Wijzigingen bekijken

Update bot: Nieuwe pagina aangemaakt met ' {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.11(EN)|1|MedicationUse2-v3.0(2024EN)}} ==General information== Name: '''nl.zorg.MedicationUse2''' link=MedicatieGebruik2-v3.0(2024NL)
Version: '''3.0'''
HCIM Status:Final
Release: '''2024''' <...'

2024-06-26T15:03:44Z

Nieuwe pagina aangemaakt met ' {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.11(EN)|1|MedicationUse2-v3.0(2024EN)}}  ==General information== Name: '''nl.zorg.MedicationUse2''' link=MedicatieGebruik2-v3.0(2024NL) Version: '''3.0''' HCIM Status:Final Release: '''2024''' <...'

Nieuwe pagina

{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.11(EN)|1|MedicationUse2-v3.0(2024EN)}}

==General information==
Name: '''nl.zorg.MedicationUse2''' [[Bestand:NL.png|link=MedicatieGebruik2-v3.0(2024NL)]] 
Version: '''3.0''' 
HCIM Status:Final 
Release: '''2024''' 
Release status: Prepublished 
Release date: 15-04-2024

{{ErrataEN|2024|{{PAGENAME}}}}

-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2024(EN)]] [[HCIM_Release_2024(EN) |Back to HCIM list ]]</div>

==Metadata==
{| class="wikitable" style="font-size:90%; width: 750px"
|-
|style="width:250px; "|DCM::CoderList||Projectgroep Medicatieproces
|-
|style="width:250px; "|DCM::ContactInformation.Address||
|-
|style="width:250px; "|DCM::ContactInformation.Name||*
|-
|style="width:250px; "|DCM::ContactInformation.Telecom||
|-
|style="width:250px; "|DCM::ContentAuthorList||Projectgroep Medicatieproces
|-
|style="width:250px; "|DCM::CreationDate||1-2-2017
|-
|style="width:250px; "|DCM::DeprecatedDate||
|-
|style="width:250px; "|DCM::DescriptionLanguage||nl
|-
|style="width:250px; "|DCM::EndorsingAuthority.Address||
|-
|style="width:250px; "|DCM::EndorsingAuthority.Name||PM
|-
|style="width:250px; "|DCM::EndorsingAuthority.Telecom||
|-
|style="width:250px; "|DCM::Id||2.16.840.1.113883.2.4.3.11.60.40.3.9.11
|-
|style="width:250px; "|DCM::KeywordList||Medicatie, Gebruik
|-
|style="width:250px; "|DCM::LifecycleStatus||Final
|-
|style="width:250px; "|DCM::ModelerList||Architectuurgroep Registratie aan de Bron
|-
|style="width:250px; "|DCM::Name||nl.zorg.MedicatieGebruik2
|-
|style="width:250px; "|DCM::PublicationDate||15-04-2024
|-
|style="width:250px; "|DCM::PublicationStatus||Prepublished
|-
|style="width:250px; "|DCM::ReviewerList||Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron
|-
|style="width:250px; "|DCM::RevisionDate||09-04-2024
|-
|style="width:250px; "|DCM::Supersedes||nl.zorg.MedicatieGebruik2-v2.1
|-
|style="width:250px; "|DCM::Version||3.0
|-
|style="width:250px; "|HCIM::PublicationLanguage||EN
|}

==Revision History==
<div class="mw-collapsible mw-collapsed">
'' Only available in Dutch''

Publicatieversie 1.0 (04-09-2017)

Publicatieversie 1.0.1 (31-12-2017)
{|
|-
|style="width:75px; "|[[ZIBIssues500_1#ZIB-618 | ZIB-618 ]]
|Hernoemen Verstrekking naar Medicatieverstrekking
|-
|style="width:75px; "|[[ZIBIssues500_1#ZIB-643 | ZIB-643 ]]
|Kleine tekstuele verbeteringen
|}

Publicatieversie 1.1 (31-01-2020)
{|
|-
|style="width:75px; "|[[ZIBIssues500_1#ZIB-906 | ZIB-906 ]]
|Typo engelse term medicatie gebruik zib
|-
|style="width:75px; "|[[ZIBIssues500_1#ZIB-888 | ZIB-888 ]]
|terminologie reden voor stoppen medicatie verbeteren en SNOMED coderingen zibs met meditatieproces gelijktrekken
|}

Publicatieversie 1.1.1 (01-09-2020)
{|
|-
|style="width:75px; "|[[ZIBIssues500_1#ZIB-911 | ZIB-911 ]]
|Correction English "Farmaceutical"
|}

Publicatieversie 1.2 (01-12-2021)
{|
|-
|style="width:75px; "|[[ZIBIssues500_2#ZIB-1261 | ZIB-1261 ]]
|Medicatieafspraak waardelijst MedicatieafspraakStopTypeCodelijst bevat vervallen SNOMED CT codes
|-
|style="width:75px; "|[[ZIBIssues500_2#ZIB-1454 | ZIB-1454 ]]
|Onduidelijkheid codes bij StopType codelijsten
|-
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1575 | ZIB-1575 ]]
|Deprecated termen en waardelijsten uit de prepublicatie halen
|}

Publicatieversie 2.0 (10-06-2022)
{|
|-
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1685 | ZIB-1685 ]]
|Medicatiebouwstenen MA, TA, MGB - engelse vertaling van 'tot en met'
|-
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1725 | ZIB-1725 ]]
|Verzameling errata bouwsteen Medicatiegebruik
|}

Publicatieversie 2.1 (15-10-2023)
{|
|-
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1965 | ZIB-1965 ]]
|Voorbeeld medicatiegebruik gebruiksduur: maand niet toegestaan
|-
|style="width:75px; "|[[ZIBIssues500_3#ZIB-1974 | ZIB-1974 ]]
|Suggested typo and textual improvements
|}

Publicatieversie 3.0 (15-04-2024)
{|
|-
|style="width:75px; "|[[ZIBIssues500_4#ZIB-2091 | ZIB-2091 ]]
|MGB/RedenWijzigenOfStoppenGebruik: toevoegen 'loopt in andere medicamenteuze behandeling'
|-
|style="width:75px; "|[[ZIBIssues500_4#ZIB-2092 | ZIB-2092 ]]
|Kardinaliteit gebruiksperiode
|-
|style="width:75px; "|[[ZIBIssues500_4#ZIB-2132 | ZIB-2132 ]]
|2023-1 Verwijzingen naar FarmaceutischProduct gebruiken verkeerde NL-CM id
|-
|style="width:75px; "|[[ZIBIssues500_4#ZIB-2133 | ZIB-2133 ]]
|2023-1 Verwijzingen naar Gebruiksinstructie gebruiken verkeerde NL-CM id
|-
|style="width:75px; "|[[ZIBIssues500_4#ZIB-2152 | ZIB-2152 ]]
|MedicatieGebruik: gebruiksindicator SNOMED koppeling
|-
|style="width:75px; "|[[ZIBIssues500_4#ZIB-2153 | ZIB-2153 ]]
|MedicatieGebruik: RedenGebruik SNOMED koppeling mist
|}
</div>

==Concept==
MedicationUse is a statement on the historic, current or intended use of a certain medicine.

==Purpose==
The goal of the medication use is to provide insight into the patient’s pattern of use.

==Information Model==
 
<imagemap> Bestand:MedicationUse2-v3.0Model(2024EN).png | center
rect 180 43 292 107 [[HealthProfessional-v4.0(2024EN)]]
rect 482 432 716 492 [[#ReasonModificationOrDiscontinuationOfUseCodeList]]
rect 746 432 946 492 [[#MedicationUseStopTypeCodeList]]
rect 746 325 888 395 [[#1601]]
rect 630 43 742 113 [[#1603]]
rect 480 43 592 107 [[InstructionsForUse-v3.0(2024EN)]]
rect 776 188 887 252 [[#1604]]
rect 330 43 442 107 [[PharmaceuticalProduct-v2.2.1(2024EN)]]
rect 775 45 887 115 [[#1609]]
rect 171 181 313 251 [[#1602]]
rect 514 326 684 396 [[#1599]]
rect 334 326 476 396 [[TimeInterval-v1.3(2024EN)]]
rect 167 325 309 395 [[#1605]]
rect 489 181 600 251 [[#1607]]
desc none
</imagemap>
 
{| border= "1" width="1500px" style = "font-size: 9.5pt; border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"
|-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; "
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
|-style="vertical-align:top; background-color: #E3E3E3; "
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
||NL-CM:9.11.21338
|colspan ="6" style ="padding-left: 0px"|[[Bestand: arrowdown.png | 10px | link=]]MedicationUse
|
|Root concept of the MedicationUse information model. This root concept contains all data elements of the MedicationUse information model.
|
{|
|-
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=422979000 422979000] Medication regimen behavior finding
|}
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.11.23290
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]Prescriber::HealthProfessional
|0..1
|The health professional that entered the medication agreement with the patient.
|
|
{|
|-
|[[Bestand: block.png | link=HealthProfessional-v4.0(2024EN)]]||[[HealthProfessional-v4.0(2024EN) |HealthProfessional]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.11.21339
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]ProductUsed::PharmaceuticalProduct
|1
|The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well.

In principle, this will be the prescribed product, but the product used may differ from the prescribed product.
|
|
{|
|-
|[[Bestand: block.png | link=PharmaceuticalProduct-v2.2.1(2024EN)]]||[[PharmaceuticalProduct-v2.2.1(2024EN) |PharmaceuticalProduct]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.11.22504
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]InstructionsForUse
|0..1
|Instructions for the use of the medication, e.g. dose and route of administration. In the event of medication use, this is the pattern of use established by the patient or that the patient followed.
|
|
{|
|-
|[[Bestand: block.png | link=InstructionsForUse-v3.0(2024EN)]]||[[InstructionsForUse-v3.0(2024EN) |InstructionsForUse]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: TS.png| 16px | link=]]
||NL-CM:9.11.22398
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]MedicationUseDateTime
|1
|Date on which this use is entered.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.11.22663
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]PeriodOfUse::TimeInterval
|1
|Medication use can be recorded for a certain moment or over a certain period. Thus, medication use can be recorded multiple times during the use of medication. The usage period is the period or moment over which the data is recorded.
Start date: This is the time at which the agreement was to take effect (or took effect or will take effect).
Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days.
End date: The time at which the period of use ends (or ended or will end). To avoid confusion between 'to' and 'up until and including', the submission of time is always mandatory for the end date.
|
|
{|
|-
|[[Bestand: block.png | link=TimeInterval-v1.3(2024EN)]]||[[TimeInterval-v1.3(2024EN) |TimeInterval]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: BL.png| 16px | link=]]
||NL-CM:9.11.22492
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]AsAgreedIndicator
|0..1
|Is the medicine used as outlined in the medication agreement?
|
{|
|-
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=112221000146107 112221000146107] Patient takes medication as prescribed
|}
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: BL.png| 16px | link=]]
||NL-CM:9.11.22399
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]UseIndicator
|1
|Is this medicine used or not?
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
||NL-CM:9.11.22491
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]ReasonForUse
|0..1
|The reason for using the medication, particularly in self-care medicine purchased by the patient themselves.
|
{|
|-
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=11611000146100 11611000146100] Reason for taking medication
|}
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:9.11.23132
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]MedicationUseStopType
|0..1
|Stop type, the manner in which this medication is discontinued (temporary or definitive).
|
|
{|
|-
|[[Bestand: List2.png | link=#MedicationUseStopTypeCodeList]]||[[#MedicationUseStopTypeCodeList|MedicationUseStopTypeCodeList]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:9.11.22493
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]ReasonModificationOrDiscontinuationOfUse
|0..*
|Reason for changing or discontinuing use of medication.
|
{|
|-
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=153861000146102 153861000146102] Reason for change of medication usage
|}
|
{|
|-
|[[Bestand: List2.png | link=#ReasonModificationOrDiscontinuationOfUseCodeList]]||[[#ReasonModificationOrDiscontinuationOfUseCodeList|ReasonModificationOrDiscontinuationOfUseCodeList]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
||NL-CM:9.11.21624
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]Comment
|0..1
|Comments on the medication use.
|
{|
|-
|[https://terminologie.nictiz.nl/art-decor/loinc?conceptId=48767-8 48767-8] Annotation comment [Interpretation] Narrative
|}
|
|}
Columns Concept and DefinitionCode: hover over the values for more information 
For explanation of the symbols, please see the legend page [[Bestand:list2.png|link=Legend]]

==Example Instances==
''Only available in Dutch''

{|class="wikitable" width="1316px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 18%; "|MedicatieGebruik DatumTijd
| style="background-color: #1F497D; width: 4%; "|GebruikIndicator
| style="background-color: #1F497D; width: 11%; "|VolgensAfspraak Indicator
| style="background-color: #1F497D; width: 11%; "|Medicatiegebruik Stoptype
|colspan="3" style="background-color: #1F497D; width: 27%; "|Gebruiksperiode
| style="background-color: #1F497D; width: 28%; "|Gebruiksproduct
|-style=vertical-align:top;
| style="background-color: #548DD4; width: 18%; "|
| style="background-color: #548DD4; width: 4%; "|
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 9%; "|Ingangsdatum
| style="background-color: #548DD4; width: 8%; "|Einddatum
| style="background-color: #548DD4; width: 9%; "|Gebruiksduur
| style="background-color: #548DD4; width: 28%; "|ProductCode
|-style=vertical-align:top;
| style="background-color: #D9D9D9; width: 18%; "|
| style="background-color: #D9D9D9; width: 4%; "|
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 9%; "|
| style="background-color: #D9D9D9; width: 8%; "|
| style="background-color: #D9D9D9; width: 9%; "|
| style="background-color: #D9D9D9; width: 28%; "|
|-style=vertical-align:top;
| style="width: 18%; "|3-6-2014 16:19:07
| style="width: 4%; "|Ja
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 9%; "|Mei 2014
| style="width: 8%; "|
| style="width: 9%; "|4 weken
| style="width: 28%; "|Paracetamol tablet 500 mg
|-style=vertical-align:top;
| style="width: 18%; "|11-9-2012 17:21:00
| style="width: 4%; "|Ja
| style="width: 11%; "|Ja
| style="width: 11%; "|
| style="width: 9%; "|01-09-12
| style="width: 8%; "|05-09-12
| style="width: 9%; "|
| style="width: 28%; "|Pantoprazol injpdr 40 mg fl
|-style=vertical-align:top;
| style="width: 18%; "|19-9-2014 4:12:11
| style="width: 4%; "|Nee
| style="width: 11%; "|Nee
| style="width: 11%; "|Definitief
| style="width: 9%; "|17-09-14
| style="width: 8%; "|
| style="width: 9%; "|
| style="width: 28%; "|Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml
|}
{|class="wikitable" width="1316px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 11%; "|RedenGebruik
| style="background-color: #1F497D; width: 11%; "|RedenWijzigen OfStoppen Gebruik
|colspan="5" style="background-color: #1F497D; width: 59%; "|GebruiksInstructie
| style="background-color: #1F497D; width: 19%; "|
|-style=vertical-align:top;
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 11%; "|
| style="background-color: #548DD4; width: 16%; "|Omschrijving
| style="background-color: #548DD4; width: 9%; "|ToedieningsWeg
| style="background-color: #548DD4; width: 11%; "|Aanvullende instructie
| style="background-color: #548DD4; width: 11%; "|Doseerinstructie
| style="background-color: #548DD4; width: 12%; "|
| style="background-color: #548DD4; width: 19%; "|
|-style=vertical-align:top;
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 16%; "|
| style="background-color: #D9D9D9; width: 9%; "|
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 11%; "|Doseerduur
| style="background-color: #D9D9D9; width: 12%; "|Dosering<noWiki>|</noWiki> Keerdosis
| style="background-color: #D9D9D9; width: 19%; "|Toedieningsschema <noWiki>|</noWiki>Frequentie <noWiki>|</noWiki>Interval <noWiki>|</noWiki>Toedientijd <noWiki>|</noWiki>Weekdag <noWiki>|</noWiki>Dagdeel 
|-style=vertical-align:top;
| style="width: 11%; "|Pijn
| style="width: 11%; "|
| style="width: 16%; "|In de maand mei heb ik regelmatig paracetamol gebruikt.
| style="width: 9%; "|
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 12%; "|
| style="width: 19%; "|
|-style=vertical-align:top;
| style="width: 11%; "|Ulcusprofylaxe
| style="width: 11%; "|
| style="width: 16%; "|Vanaf 1 september 2012 gedurende 5 dagen 1x per dag om 8uur 40 mg (=1 st)
| style="width: 9%; "|iv
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 12%; "|40 mg (=1 st)
| style="width: 19%; "|1x per dag om 8.00 uur
|-style=vertical-align:top;
| style="width: 11%; "|
| style="width: 11%; "|(Mogelijke) bijwerking
| style="width: 16%; "|Tijdelijk gestopt vanwege toenemende bijwerkingen: duizeligheid en misselijkheid.
| style="width: 9%; "|subcutaan
| style="width: 11%; "|
| style="width: 11%; "|
| style="width: 12%; "|2500 IE
| style="width: 19%; "|1x per dag om 18.00 uur 
|}

== Valuesets ==
=== MedicationUseStopTypeCodeList===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.1
|Binding: Extensible
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|Drug therapy temporarily stopped
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=113381000146106 113381000146106]
|SNOMED CT
|2.16.840.1.113883.6.96
|Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie).
|-style="vertical-align:top; "
|Drug therapy definitely stopped
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=113371000146109 113371000146109]
|SNOMED CT
|2.16.840.1.113883.6.96
|Het staken van een bestaande medicamenteuze behandeling.
|}
=== ReasonModificationOrDiscontinuationOfUseCodeList===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.2
|Binding: Extensible
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|Medication commenced
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=266709005 266709005]
|SNOMED CT
|2.16.840.1.113883.6.96
|Starten medicamenteuze behandeling [DEPRECATED]
|-style="vertical-align:top; "
|Administration of medication contraindicated
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=438833006 438833006]
|SNOMED CT
|2.16.840.1.113883.6.96
|Contra-indicatie
|-style="vertical-align:top; "
|Medication interaction
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=79899007 79899007]
|SNOMED CT
|2.16.840.1.113883.6.96
|Interactie
|-style="vertical-align:top; "
|Adverse reaction to drug
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=62014003 62014003]
|SNOMED CT
|2.16.840.1.113883.6.96
|Overgevoeligheid
|-style="vertical-align:top; "
|Hypersensitivity condition
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=473010000 473010000]
|SNOMED CT
|2.16.840.1.113883.6.96
|Overgevoeligheid [DEPRECATED]
|-style="vertical-align:top; "
|Lack of drug action
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=58848006 58848006]
|SNOMED CT
|2.16.840.1.113883.6.96
|Geen of onvoldoende effect
|-style="vertical-align:top; "
|Drug action too strong
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=112251000146103 112251000146103]
|SNOMED CT
|2.16.840.1.113883.6.96
|Te sterk effect
|-style="vertical-align:top; "
|At increased risk of medication side effect
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=704417003 704417003]
|SNOMED CT
|2.16.840.1.113883.6.96
|(Mogelijke) bijwerking [DEPRECATED]
|-style="vertical-align:top; "
|Insufficient route of drug administration
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=112191000146101 112191000146101]
|SNOMED CT
|2.16.840.1.113883.6.96
|Toedieningsweg voldoet niet
|-style="vertical-align:top; "
|Drug treatment not indicated
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=183966005 183966005]
|SNOMED CT
|2.16.840.1.113883.6.96
|Indicatie vervallen
|-style="vertical-align:top; "
|Medication management changed
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=112751000146109 112751000146109]
|SNOMED CT
|2.16.840.1.113883.6.96
|Beleidswijziging
|-style="vertical-align:top; "
|Admission to establishment
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=305335007 305335007]
|SNOMED CT
|2.16.840.1.113883.6.96
|Opname
|-style="vertical-align:top; "
|Patient requested modification of treatment
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=159711000146106 159711000146106]
|SNOMED CT
|2.16.840.1.113883.6.96
|verzoek van zorgafnemer om behandeling te wijzigen Verzoek van zorgafnemer om behandeling te wijzigen
|-style="vertical-align:top; "
|Patient requested treatment
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=184003006 184003006]
|SNOMED CT
|2.16.840.1.113883.6.96
|Wens patiënt [DEPRECATED]
|-style="vertical-align:top; "
|Patient takes medication as prescribed
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=112221000146107 112221000146107]
|SNOMED CT
|2.16.840.1.113883.6.96
|Medicatiegebruik van patiënt volgens afspraak
|-style="vertical-align:top; "
|Patient agreed with treatment
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=112211000146102 112211000146102]
|SNOMED CT
|2.16.840.1.113883.6.96
|Volgens afspraak [DEPRECATED]
|-style="vertical-align:top; "
|Treatment previous prescriber continued
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=112261000146100 112261000146100]
|SNOMED CT
|2.16.840.1.113883.6.96
|Hervatten beleid vorige voorschrijver
|-style="vertical-align:top; "
|Change in laboratory test finding
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=160131000146104 160131000146104]
|SNOMED CT
|2.16.840.1.113883.6.96
|Verandering in labwaarde
|-style="vertical-align:top; "
|Drug not available - out of stock
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=182856006 182856006]
|SNOMED CT
|2.16.840.1.113883.6.96
|Geneesmiddel niet voorradig
|-style="vertical-align:top; "
|Incorrect registration of medication
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=159691000146109 159691000146109]
|SNOMED CT
|2.16.840.1.113883.6.96
|Foutieve registratie van medicatie
|-style="vertical-align:top; "
|Planned procedure
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=405613005 405613005]
|SNOMED CT
|2.16.840.1.113883.6.96
|Procedure waaronder ingreep, interferentie met gepland labonderzoek, etc.
|-style="vertical-align:top; "
|Double registration of medication treatment
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=180011000146107 180011000146107]
|SNOMED CT
|2.16.840.1.113883.6.96
|Loopt in andere medicamenteuze behandeling
|-style="vertical-align:top; "
|Overig
|OTH
|NullFlavor
|2.16.840.1.113883.5.1008
|Overig
|}

==This information model in other releases==

{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.11(EN)|2|2024}}

==Information model references==
====This information model refers to====
*[[HealthProfessional-v4.0(2024EN)|HealthProfessional-v4.0]]
*[[InstructionsForUse-v3.0(2024EN)|InstructionsForUse-v3.0]]
*[[PharmaceuticalProduct-v2.2.1(2024EN)|PharmaceuticalProduct-v2.2.1]]
*[[TimeInterval-v1.3(2024EN)|TimeInterval-v1.3]]
====This information model is used in====
:--
==Technical specifications in HL7v3 CDA and HL7 FHIR==
To exchange information based on health and care information models, additional, more technical specifications are required. 
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
<ul>
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment {{ArtDecorLinks|2024|9.11}}</li>
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR {{SimplefierLinks|2024|MedicatieGebruik2}}</li>
</ul>
==Downloads==
This information model is also available as [[Media:nl.zorg.MedicationUse2-v3.0(2024EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationUse2-v3.0(2024EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
==About this information==
The information in this wikipage is based on Prerelease 2024-1 
SNOMED CT and LOINC codes are based on:
<ul>
<li>SNOMED Clinical Terms versie: 20240331 [R] (maart 2024-editie)</li>
<li>LOINC version 2.77</li>
</ul>
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]] 
This page is generated on 25/04/2024 12:41:36 with ZibExtraction v. 9.3.8880.19756 
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2024(EN)]] [[HCIM_Release_2024(EN) |Back to HCIM list ]]</div>

MedicationUse2-v3.0(2024EN) - Bewerkingsoverzicht

Update bot op 27 mei 2025 om 15:55

Update bot op 18 apr 2025 om 16:24

Update bot: Nieuwe pagina aangemaakt met ' {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.11(EN)|1|MedicationUse2-v3.0(2024EN)}} ==General information== Name: '''nl.zorg.MedicationUse2''' link=MedicatieGebruik2-v3.0(2024NL) Version: '''3.0''' HCIM Status:Final Release: '''2024''' <...'

Update bot: Nieuwe pagina aangemaakt met ' {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.9.11(EN)|1|MedicationUse2-v3.0(2024EN)}} ==General information== Name: '''nl.zorg.MedicationUse2''' link=MedicatieGebruik2-v3.0(2024NL)
Version: '''3.0'''
HCIM Status:Final
Release: '''2024''' <...'